You are here: Industry Insights > CKD

News List

AZ' Farxiga hits all goals in chronic kidney disease trial pharmatimes
July 29, 2020
AstraZeneca's Farxiga’s (dapagliflozin) has hit all primary and secondary endpoints in a late stage trial assessing its use in patients with chronic kidney disease (CKD).
Ardelyx Submits NDA for Tenapanor americanpharmaceuticalreview
July 10, 2020
Ardelyx announced the submission of a New Drug Application (NDA) for tenapanor to the U.S. Food and Drug Administration (FDA) for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis.
Emcure launches India first generic version of sucroferric oxyhydroxide for chronic kidney disease patients expresspharma
July 02, 2020
Dynulta, the drug's brand name, will be manufactured at Emcure's state-of-the-art plant at Jammu and will be marketed at less than 70 per cent cost of the innovator brand.
Japan grants approval for GSK’s Duvroq to treat CKD-related anaemia pharmaceutical-technology
June 30, 2020
Japan’s Ministry of Health, Labour and Welfare has granted the first regulatory approval for GlaxoSmithKline (GSK)’s Duvroq (daprodustat) to treat anaemia caused by chronic kidney disease (CKD).
Novo snaps up cardio-renal group Corvidia pharmatimes
June 16, 2020
Novo Nordisk has signed a deal to acquire Corvidia Therapeutics, a privately held, clinical stage company with a focus on the research and development of transformative therapies for cardio-renal diseases.
New COVID-19 guidelines for CKD and interstitial lung disease pharmatimes
May 19, 2020
The National Institute for Health and Care Excellence has published two new rapid COVID-19 guidelines for chronic kidney disease (CKD) and interstitial lung disease.
Cara Therapeutics Announces Positive Topline Data from Oral KORSUVA Trial americanpharmaceuticalreview
December 30, 2019
Cara Therapeutics announced positive topline results from its Phase 2 dose-ranging trial of Oral KORSUVA™ (CR845/difelikefalin) for the treatment of pruritus in patients with ...
Potentially Nephrotoxic Meds Prescribed to Children With CKD drugs
December 25, 2019
Potentially nephrotoxic medications are prescribed at a higher rate to children with versus without chronic kidney disease (CKD), according to a study published online in the Clinical Journal of the American Society of Nephrology.
Healthy Dietary Patterns Linked to Lower Incidence of CKD drugs
September 26, 2019
A healthy dietary pattern is associated with a reduced incidence of chronic kidney disease and albuminuria, according to a review published online in the Clinical Journal of the American Society of Nephrology.
Guideline Updated for Prevention, Management of Hep C in CKD drugs
September 24, 2019
In a synopsis of the 2018 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline, published online in the Annals of Internal Medicine, updated recommendations are presented for the prevention...

Previous page 1 2 3 4 5 6 Next page